Table 1.
Demographics and other descriptors for entire sample and by presence of agitation (at least one observation of agitation during the study period).
| Entire sample n = 200 | Non-agitated Pts n = 82 (41%) | Agitated Pts n = 118 (59%) | |
|---|---|---|---|
|
| |||
| Variable | n (%) | n (%) | n (%) |
| Gender | |||
| Male | 113 (56.5) | 42 (51) | 73 (62) |
| Female | 87 (43.5) | 40 (49) | 45 (38) |
| Ethnicity | |||
| Hispanic or Latino | 6 (3) | 5 (6) | 1 (1) |
| Not Hispanic or Latino | 194 (97) | 77 (94) | 117 (99) |
| Race | |||
| Asian | 3 (1.5) | 2 (2) | 1 (1) |
| Black or African American | 94 (47) | 39 (48) | 55 (47) |
| White | 103 (51.5) | 41 (50) | 62 (53) |
| ICU Type | |||
| Medical Respiratory ICU | 100 (50) | 36 (44) | 64 (54) |
| Surgical Trauma ICU | 100 (50) | 46 (56) | 54 (46) |
| Admission Source | |||
| Long term care | 3 (1.5) | 2 (1) | 1 (0.5) |
| Home | 16 (8) | 4 (2) | 12 (6) |
| Clinic | 20 (10) | 7 (3.5) | 13 (6.5) |
| Outside hospital | 60 (30) | 23 (11.5) | 37 (18.5) |
| ED | 101 (50.5) | 46 (23) | 55 (27.5) |
| Admitting Diagnosis | |||
| Trauma | 36 (18) | 18 (22) | 18 (15) |
| Sepsis | 35 (17.5) | 17 (21) | 18 (15) |
| Respiratory failure | 27 (13.5) | 6 (7) | 21 (18) |
| Hematologic/oncologic problem | 27 (13.5) | 8 (10) | 20 (17) |
| Other | 22 (11) | 9 (11) | 12 (10) |
| Renal/GI problem/DKA | 28 (14) | 15 (19) | 13 (11) |
| Hepatic problem | 13 (6.5) | 4 (5) | 9 (8) |
| Cardiovascular problem | 8 (4) | 4 (5) | 4 (3) |
| Drug overdose/poisoning | 4 (2) | 1 (1) | 3 (3) |
| Intubated* | 118 (59) | 20 (17) | 98 (83) |
|
| |||
| Variable | Mean (Range, SD) | Mean (Range, SD) | Mean (Range, SD) |
|
| |||
| Age (years) | 55.5 (18–89; +/− 16.4) | 56 (19–87; +/− 16.4) | 55.1 (18–89; +/− 16.5) |
| ICU length of stay (days) | 7.1 (1–99.4; +/− 9.7) | 5.9 (1–99.4; +/− 12.1) | 7.9 (1.5–36.2; +/− 7.6) |
| Hospital length of stay (days) | 16.6 (1–99.5; +/− 15.3) | 15.8 (1–99.5; +/− 16.3) | 17.1 (2.2–79; +/− 14.7) |
| APACHE III score13 | 68 (4–200; +/− 31.9) | 57.7 (4–200; +/− 34.3) | 74.7 (21–170; +/− 28.2) |
| SOFA14 | 6.625 (0–18; +/− 3.8) | 5.39 (1–17; +/− 3.7) | 7.48 (0–18 ; +/− 3.7) |
| Charlson Comorbidity Index15 | 4.69 (0–17; +/− 3.3) | 4.8 (0–13; +/− 3.3) | 4.6 (0–17; +/− 3.4) |
Abbr: intensive care unit (ICU); emergency department (ED); diabetic ketoacidosis (DKA); Acute Physiology and Chronic Health Evaluation III (APACHE III); Sequential Organ Failure Assessment (SOFA)
*
There was no difference between the numbers of intubated patients in the 2 ICUs